
Tyra Biosciences, Inc. Share Price
TYRA
$12.41
-$0.08 (-0.64%) Last updated on 04 Sep, 2025 | 00:16 ISTTyra Biosciences, Inc. Stock Performance
Open $12.92 | Prev. Close $12.49 | Circuit Range N/A |
Day Range $12.36 - $12.94 | Year Range $6.42 - $29.60 | Volume 14,276 |
Average Traded $12.57 |
Tyra Biosciences, Inc. Share Price Chart
$12.41
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
03-Sep-25 | $12.92 | $12.36 | +0.00% |
03-Sep-25 | $12.92 | $12.36 | -1.08% |
02-Sep-25 | $12.64 | $12.49 | -1.03% |
29-Aug-25 | $12.40 | $12.63 | +2.10% |
28-Aug-25 | $13.02 | $12.37 | -4.18% |
27-Aug-25 | $12.59 | $12.90 | +1.77% |
26-Aug-25 | $12.17 | $12.68 | +6.64% |